BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31281953)

  • 1. Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway.
    Cha Z; Cheng J; Xiang H; Qin J; He Y; Peng Z; Jia J; Yu H
    Cancer Chemother Pharmacol; 2019 Oct; 84(4):719-728. PubMed ID: 31281953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors.
    Sung B; Park B; Yadav VR; Aggarwal BB
    J Biol Chem; 2010 Apr; 285(15):11498-507. PubMed ID: 20154087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone IIA sensitizes TRAIL-induced apoptosis in glioblastoma through inducing the expression of death receptors (and suppressing STAT3 activation).
    Zhou X; Lv L; Tan Y; Zhang Z; Wei S; Xiao S
    Brain Res; 2021 Sep; 1766():147515. PubMed ID: 33984327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
    Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
    Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH; Yoon MJ; Kim SU; Kwon TK; Sohn S; Choi KS
    Cancer Res; 2008 Jan; 68(1):266-75. PubMed ID: 18172319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J; Wang Y; Liu L; Yuan Y; Bao Y
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway.
    Khan M; Bi Y; Qazi JI; Fan L; Gao H
    Mol Med Rep; 2015 Jan; 11(1):257-62. PubMed ID: 25333675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.
    Karpel-Massler G; Pareja F; Aimé P; Shu C; Chau L; Westhoff MA; Halatsch ME; Crary JF; Canoll P; Siegelin MD
    PLoS One; 2014; 9(12):e114583. PubMed ID: 25531448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC; Kuan CP; Lin JY; Lai JS; Ho TF
    Chem Res Toxicol; 2015 Aug; 28(8):1574-83. PubMed ID: 26203587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.
    Zhu H; Liu XW; Ding WJ; Xu DQ; Zhao YC; Lu W; He QJ; Yang B
    Cancer Lett; 2010 Nov; 297(2):155-64. PubMed ID: 20605676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation.
    Kim IY; Kang YJ; Yoon MJ; Kim EH; Kim SU; Kwon TK; Kim IA; Choi KS
    Neuro Oncol; 2011 Mar; 13(3):267-79. PubMed ID: 21292685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
    Tse AK; Chow KY; Cao HH; Cheng CY; Kwan HY; Yu H; Zhu GY; Wu YC; Fong WF; Yu ZL
    J Biol Chem; 2013 Oct; 288(41):29923-33. PubMed ID: 23986445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
    Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
    Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5.
    Kang YJ; Kim IY; Kim EH; Yoon MJ; Kim SU; Kwon TK; Choi KS
    Exp Mol Med; 2011 Jan; 43(1):24-34. PubMed ID: 21150246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Death Receptor 5 and Production of Reactive Oxygen Species Mediate Sensitization of PC-3 Prostate Cancer Cells to TRAIL Induced Apoptosis by Vitisin A.
    Shin D; Kwon HY; Sohn EJ; Nam MS; Kim JH; Lee JC; Ryu SY; Park B; Kim SH
    Cell Physiol Biochem; 2015; 36(3):1151-62. PubMed ID: 26111475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
    James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
    Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NVP-BKM120 potentiates apoptosis in tumor necrosis factor-related apoptosis-inducing ligand-resistant glioma cell lines via upregulation of Noxa and death receptor 5.
    Foster KA; Jane EP; Premkumar DR; Morales A; Pollack IF
    Int J Oncol; 2015 Aug; 47(2):506-16. PubMed ID: 26044191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-allyl-7-gen-difluoromethoxychrysin enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells.
    Xie ZH; Quan MF; Liu F; Cao JG; Zhang JS
    BMC Cancer; 2011 Jul; 11():322. PubMed ID: 21801359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis.
    Weinmann L; Wischhusen J; Demma MJ; Naumann U; Roth P; Dasmahapatra B; Weller M
    Cell Death Differ; 2008 Apr; 15(4):718-29. PubMed ID: 18202704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells.
    Jin CY; Park C; Hwang HJ; Kim GY; Choi BT; Kim WJ; Choi YH
    Mol Nutr Food Res; 2011 Feb; 55(2):300-9. PubMed ID: 20669244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.